Cell culture models of the ocular barriers
- PMID: 15939234
- DOI: 10.1016/j.ejpb.2005.01.009
Cell culture models of the ocular barriers
Abstract
The presence of tight barriers, which regulate the environment of ocular tissues in the anterior and posterior part of the eye, is essential for normal visual function. The development of strategies to overcome these barriers for the targeted ocular delivery of drugs, e.g. to the retina, remains a major challenge. During the last years numerous cell culture models of the ocular barriers (cornea, conjunctiva, blood-retinal barrier) have been established. They are considered to be promising tools for studying the drug transport into ocular tissues, and for numerous other purposes, such as the investigation of pathological ocular conditions, and the toxicological screening of compounds as alternative to in vivo toxicity tests. The further development of these in vitro models will require more detailed investigations of the barrier properties of both the cell culture models and the in vivo ocular barriers. It is the aim of this review to describe the current status in the development of cell culture models of the ocular barriers, and to discuss the applicability of these models in pharmaceutical research.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration.Exp Eye Res. 2004 Apr;78(4):815-22. doi: 10.1016/j.exer.2003.10.020. Exp Eye Res. 2004. PMID: 15037116
-
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.Eur J Pharm Biopharm. 2017 Jan;110:70-75. doi: 10.1016/j.ejpb.2016.10.009. Epub 2016 Oct 24. Eur J Pharm Biopharm. 2017. PMID: 27789358 Review.
-
RMP-7, a bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig.Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2542-7. Invest Ophthalmol Vis Sci. 1995. PMID: 7591644
-
Drug delivery to the posterior segment of the eye.Drug Discov Today. 2011 Mar;16(5-6):270-7. doi: 10.1016/j.drudis.2010.12.004. Epub 2010 Dec 15. Drug Discov Today. 2011. PMID: 21167306 Review.
Cited by
-
Cellular models and therapies for age-related macular degeneration.Dis Model Mech. 2015 May;8(5):421-7. doi: 10.1242/dmm.017236. Dis Model Mech. 2015. PMID: 26035859 Free PMC article. Review.
-
Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.Drug Deliv Transl Res. 2021 Jun;11(3):984-999. doi: 10.1007/s13346-020-00810-8. Drug Deliv Transl Res. 2021. PMID: 32567039
-
Nanocarriers for ocular drug delivery: current status and translational opportunity.RSC Adv. 2020 Jul 24;10(46):27835-27855. doi: 10.1039/d0ra04971a. eCollection 2020 Jul 21. RSC Adv. 2020. PMID: 35516960 Free PMC article. Review.
-
Overview of Recent Advances in Nano-Based Ocular Drug Delivery.Int J Mol Sci. 2023 Oct 19;24(20):15352. doi: 10.3390/ijms242015352. Int J Mol Sci. 2023. PMID: 37895032 Free PMC article. Review.
-
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.Recent Pat Nanomed. 2012;2(2):82-95. doi: 10.2174/1877912311202020082. Recent Pat Nanomed. 2012. PMID: 25400717 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical